secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sarepta Therapeutics, Inc. (SRPT)
CIK:        0000873303
Form:       8-K
Filed at:   2026-02-25T23:59:59+00:00
Accession:  0001193125-26-072064
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Sarepta CEO Douglas Ingram to retire by end of 2026; successor search underway
------------------------------------------------------------------------------

- CEO Douglas Ingram notified retirement by end of 2026 or upon appointment of replacement.
- Board has commenced search for successor, considering internal and external candidates.
- Ingram will remain CEO until successor is appointed or through 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/873303/000119312526072064/0001193125-26-072064-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/873303/000119312526072064/srpt-20260225.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-072064

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer